Eric Buckland

Eric Buckland

Company: Translational Imaging Innovations (TII)

Job title: Founder & Chief Executive Officer


Data Solutions for Imaging Biomarker Discovery and Clinical Endpoint Validation 12:00 pm

Dearth of meaningful endpoints remains hurdle in ophthalmic gene therapy trials Biomarkers and endpoints are not born, they are discovered and validated Clinical standards of care are insufficient, and must be supported with emerging imaging modalities and analysesRead more

day: Day Two Track B - Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.